Companies: 10,795ยทTotal market cap: $144.5T
Next Science Limited

Next Science Limited

NXSCFOTCHealthcare
$0.00
$-0.02(-93.75%)
Market Cap$292625
P/E Ratioโ€”
52W High$0.1133
52W Low$0.0002
Overview

Next Science Limited (NXSCF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

NXSCF ยท earnings ยท updated Jun 9, 2026

Latest Earnings

Q3 FY2025
EPS Actual
-$0.01
Revenue
$0.01B
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Sep 4, 2025
After Market Close
๐Ÿ”ฅ 5-Quarter EPS Beat Streak
NXSCF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP ยท Updated hourly.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.โ€”
Rev. Est.$1.10B

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q1 FY2026
Feb 26, 2026
EPS Actual
โ€”
EPS Est.
โ€”
EPS Surpr.
โ€”
Revenue
โ€”
Q3 FY2025
Sep 4, 2025
EPS Actual
-$0.01
EPS Est.
โ€”
EPS Surpr.
โ€”
Revenue
$0.01B
Q2 FY2025
Apr 24, 2025
EPS Actual
โ€”
EPS Est.
โ€”
EPS Surpr.
โ€”
Revenue
โ€”
Q1 FY2025
Feb 28, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.02
EPS Surpr.
+50.5%
Revenue
$0.01B
Q4 FY2024
Oct 21, 2024
EPS Actual
โ€”
EPS Est.
โ€”
EPS Surpr.
โ€”
Revenue
โ€”
Q3 FY2024
Jul 24, 2024Beat
EPS Actual
-$0.01
EPS Est.
-$0.02
EPS Surpr.
+64.8%
Revenue
$0.00B
Q2 FY2024
Apr 23, 2024
EPS Actual
-$0.01
EPS Est.
โ€”
EPS Surpr.
โ€”
Revenue
$0.00B
Q1 FY2024
Feb 27, 2024Beat
EPS Actual
-$0.02
EPS Est.
-$0.03
EPS Surpr.
+19.6%
Revenue
$0.01B

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
PeriodLowConsensusHigh# Analysts
Q2 FY2024$-0.02$-0.02$-0.021
Q4 FY2023$-0.03$-0.03$-0.031
Revenue Estimates
PeriodLowConsensusHigh# Analysts
Q2 FY2024$0.0B$0.0B$0.0B1
Q4 FY2023$0.0B$0.0B$0.0B1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q3 FY2025+0.00%
Report Date
Sep 4, 2025
EPS Beat/Miss
โ€”
Price Before
$0.06
Price After
$0.06
Q1 FY2025+0.00%
Report Date
Feb 28, 2025
EPS Beat/Miss
+50.5%
Price Before
$0.09
Price After
$0.09
Q3 FY2024+0.00%
Report Date
Jul 24, 2024
EPS Beat/Miss
+64.8%
Price Before
$0.20
Price After
$0.20
Q2 FY2024-16.00%
Report Date
Apr 23, 2024
EPS Beat/Miss
โ€”
Price Before
$0.27
Price After
$0.23
Q1 FY2024-0.63%
Report Date
Feb 27, 2024
EPS Beat/Miss
+19.6%
Price Before
$0.24
Price After
$0.24
Q1 FY2024-4.68%
Report Date
Jan 30, 2024
EPS Beat/Miss
โ€”
Price Before
$0.24
Price After
$0.23
Q2 FY2023-0.12%
Report Date
Jun 29, 2023
EPS Beat/Miss
โ€”
Price Before
$0.38
Price After
$0.38
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
+25.2%
Price Before
$0.46
Price After
$0.46
Avg Beat Reaction-0.16%
Beat Rate4 / 8 quarters
Largest Move-16.00% (Q2 FY2024)
Data: FMP /historical-price-eod/full ยท field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)ย ย |ย ย Updated: Hourlyย ย |ย ย Surprise%: (Actual โˆ’ Estimate) / |Estimate| ร— 100ย ย |ย ย Fiscal year: NXSCF ends December

Next Science Limited (NXSCF) most recently reported earnings on September 4, 2025 for Q3 FY2025, posting EPS of $-0.01 (in line with the analyst consensus of โ€”). NXSCF has beaten EPS estimates for 5 consecutive quarters. The next NXSCF earnings date is expected around September 1, 2026.

Each quarter, investors track NXSCF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NXSCF revenue tab โ†’

Earnings Glossary
EPS (Earnings Per Share)
Net income รท diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual โˆ’ Estimate) / |Estimate| ร— 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual โ‰ฅ Estimate. Miss = Actual < Estimate. In-Line = within ยฑ1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NXSCF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

NXSCF earnings ยท 4 questions

Next Science Limited's next earnings report is expected around September 1, 2026. NXSCF typically reports quarterly โ€” approximately every three months. The exact date is confirmed by the company 2โ€“4 weeks before the release. Time is currently TBD; NXSCF historically reports after market close (AMC).

NXSCF earnings datewhen is NXSCF earningsNXSCF next earnings datewhen does NXSCF report earningsNXSCF earnings calendar

โ–ธ Source: FMP ยท Next Science Limited SEC filings ยท US GAAP ยท Next Science Limited SEC 10-K & 10-Q filings ยท US GAAP ยท Updated: Jun 9, 2026